According to the randomization procedure, Group 1 was assigned to the novel methylcobalamin nasal spray (NASO B12) and Group 2 was assigned to methylcobalamin oral tablet for the treatment of vitamin B12 deficiency during the study period of 15 days [Figure 1]
Running the numbers through a calculator prevents the kind of mistakes that lead to unexplained lack of results or sudden onset of side effects like headaches
But theres a pattern to who tends to seek it out and who may be a reasonable candidate after a proper evaluation
Your doctor may recommend changing the dosage
On his podcast, Andrew Huberman, MD, professor of neurobiology and ophthalmology at Stanford Universitys school of medicine, shared a potential, and slightly gory, origin story for BPC-157
Its not an aid-all, but a potential tool